Biosensor Can Detect Airborne Bird Flu in Under Five Minutes
A portable biosensor cuts detection time for airborne H5N1 virus particles to less than five minutes -- significantly faster than conventional PCR tests.
Tag: testing influenza
All
Latest
Biosensor Can Detect Airborne Bird Flu in Under Five Minutes
A portable biosensor cuts detection time for airborne H5N1 virus particles to less than five minutes — significantly faster than conventional PCR tests.
Read More
FDA Clears Visby Medical Flu + COVID Test
Visby Medical’s handheld PCR test that differentiates between influenza A, B, and COVID-19 received FDA clearance and a CLIA waiver.
Read More
Wearable Alerts for Respiratory Infections Spur Few to Get Tested
While wearables can detect potential respiratory infections, a new study shows that only a quarter of individuals follow up with at-home testing.
Read More
The CDC’s Test for Bird Flu Works, but It Has Issues
The Centers for Disease Control and Prevention says a glitch in its bird flu test hasn’t harmed the agency’s outbreak response.
Read More
FDA Clears Biofire Spotfire Respiratory/Sore Throat Panel Mini
bioMérieux’s Biofire Spotfire Respiratory/Sore Throat (R/ST) Panel Mini received US FDA Special 510(k) clearance and CLIA-waiver, according to the company.
Read More
‘We’re Flying Blind’: CDC Has 1M Bird Flu Tests Ready, but Experts See Repeat of Covid Missteps
Despite the US government’s announcement of a bird flu outbreak on dairy farms nearly three months ago, only about 45 people have been tested nationwide, according to health experts.
Read More
FDA Authorizes Roche 4-in-1 Test for SARS-CoV-2, Influenza A/B, RSV
The FDA issued emergency use authorization to Roche’s cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test, the company reports.
Read More
CDC Calls for Heightened Flu Monitoring to Detect Rare Human H5N1 Cases
This enhanced monitoring aims to quickly detect any rare cases of human infection with the H5N1 bird flu virus.
Read More
FDA Clears QIAstat-Dx Respiratory Syndromic Testing Panel
Previously authorized under an FDA EUA, the panel helps diagnose upper respiratory infections, covering 21 viral and bacterial targets.
Read More
FDA Authorizes Opti Medical COVID-19/Flu Test
The US FDA granted Emergency Use Authorization for the Opti SARS-CoV-2/Influenza A/B RT-PCR Test from OPTI Medical Systems.
Read More
FDA Approves Abbott Influenza A & B and Strep A Assays
The US FDA has cleared Abbott’s next-generation Influenza A & B 2 and Strep A 2 molecular assays for point-of-care testing.
Read More
FDA Green-lights Alere i Influenza A & B 2 Diagnostic
The Alere i Influenza A & B 2 test has received 510(k) marketing clearance from the US FDA for the detection of influenza A and B infection in children and adults, according to Alere Inc.
Read More
BD Launches Wireless POC Diagnostic for Flu, RSV
The new wireless BD Veritor Plus System provides clinicians and laboratorians with rapid, lab-quality immunoassay test results for influenza A/B, RSV, and group A strep.
Read More